T36.7X Poisoning by, adverse effect of and underdosing of antifungal antibiotics, systemically used

Name of the Condition

• Poisoning by, adverse effect of and underdosing of antifungal antibiotics, systemically used

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to systemically used antifungal antibiotics. It includes cases where exposure to these agents leads to harmful effects, unintended reactions, or insufficient therapeutic levels. Documentation should specify the type of antifungal, intent (e.g., accidental, therapeutic error), and encounter details.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose of antifungal antibiotics, incorrect administration, or allergic reactions. Underdosing occurs when therapeutic levels are not achieved, often due to dosing errors, non-adherence, or inadequate prescription. Adverse effects can stem from drug interactions, idiosyncratic reactions, or cumulative toxicity.

Risk Factors

• Prior history of antifungal allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., nephrotoxicity).
• Underdosing: Persistent infection, treatment failure.

Diagnosis

Evaluation includes patient history of antifungal use, clinical assessment of symptoms, and laboratory tests to confirm drug levels or identify toxic effects. Documentation must clarify the nature of the event (poisoning, adverse effect, or underdosing) to guide coding.

Treatment Options

Treatment depends on the specific antifungal, severity of exposure, and clinical presentation. For poisoning, decontamination or supportive care may be required. Adverse effects may necessitate discontinuation or dose adjustment. Underdosing often requires therapeutic monitoring and regimen optimization.

Prognosis and Follow-Up

Prognosis varies based on the extent of exposure, underlying health, and timely intervention. Follow-up includes monitoring for recurrence of symptoms, infection resolution, or adverse effects. Long-term management may involve medication adjustments or patient education.

Complications

Severe cases may lead to organ damage, treatment-resistant infections, or life-threatening reactions. Chronic underdosing can result in persistent or worsening infections.

Lifestyle & Prevention

• Adhere to prescribed dosing schedules and instructions.
• Avoid self-adjusting medication without provider guidance.
• Report any unusual symptoms or side effects promptly.
• Ensure proper storage and handling of antifungal antibiotics.

When to Seek Professional Help

Seek immediate care for signs of severe allergic reactions (e.g., anaphylaxis), overdose symptoms (e.g., confusion, organ dysfunction), or persistent infection despite treatment.

Tips for Medical Coders

Document the type of antifungal antibiotic, intent of exposure (e.g., accidental, therapeutic error), and clinical details to support accurate coding. Specify whether the event is poisoning, adverse effect, or underdosing to align with the code’s definition.